Safety and efficacy of ruxolitinib in a profoundly thrombocytopenic patient with myelofibrosis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2015-04, Vol.94 (4), p.711-712
Hauptverfasser:	Armstrong, C., Maung, S. W., Neary, P., McHugh, J., Enright, H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Agents - therapeutic use Drug-Related Side Effects and Adverse Reactions Hematology Humans Letter to the Editor Male Medicine Medicine & Public Health Oncology Primary Myelofibrosis - complications Primary Myelofibrosis - drug therapy Pyrazoles - therapeutic use Severity of Illness Index Thrombocytopenia - complications Thrombocytopenia - drug therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!